Erste Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.62M Buy
29,810
+6,500
+28% +$2.1M 0.08% 205
2025
Q1
$6.26M Sell
23,310
-3,200
-12% -$859K 0.08% 204
2024
Q4
$6.31M Buy
26,510
+10,000
+61% +$2.38M 0.08% 215
2024
Q3
$4.54M Sell
16,510
-12,000
-42% -$3.3M 0.05% 250
2024
Q2
$7.04M Hold
28,510
0.09% 184
2024
Q1
$4.4M Hold
28,510
0.06% 241
2023
Q4
$5.58M Hold
28,510
0.08% 204
2023
Q3
$4.96M Hold
28,510
0.09% 204
2023
Q2
$5.45M Hold
28,510
0.1% 206
2023
Q1
$5.56M Hold
28,510
0.11% 195
2022
Q4
$6.79M Sell
28,510
-2,420
-8% -$576K 0.14% 165
2022
Q3
$6.48M Sell
30,930
-5,000
-14% -$1.05M 0.15% 172
2022
Q2
$5.23M Hold
35,930
0.12% 195
2022
Q1
$5.94M Sell
35,930
-870
-2% -$144K 0.11% 196
2021
Q4
$6.26M Hold
36,800
0.11% 185
2021
Q3
$6.53M Sell
36,800
-5,800
-14% -$1.03M 0.13% 175
2021
Q2
$7.07M Hold
42,600
0.14% 167
2021
Q1
$5.76M Hold
42,600
0.14% 168
2020
Q4
$5.56M Sell
42,600
-13,000
-23% -$1.7M 0.15% 165
2020
Q3
$8.06M Sell
55,600
-15,500
-22% -$2.25M 0.28% 106
2020
Q2
$10.5M Hold
71,100
0.42% 77
2020
Q1
$7.74M Sell
71,100
-5,200
-7% -$566K 0.45% 64
2019
Q4
$8.97M Buy
76,300
+1,400
+2% +$165K 0.4% 64
2019
Q3
$6.07M Buy
74,900
+11,800
+19% +$957K 0.32% 85
2019
Q2
$4.49M Hold
63,100
0.24% 111
2019
Q1
$5.72M Hold
63,100
0.32% 83
2018
Q4
$4.33M Buy
+63,100
New +$4.33M 0.29% 88